PD‐1 inhibits T‐cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ

Kelly-Ann Sheppard(Inflammation Research Foundation), Lori Fitz(Inflammation Research Foundation), Julie M. Lee(Inflammation Research Foundation), Christina Benander(Inflammation Research Foundation), Judith A. St. George(Inflammation Research Foundation), Joe Wooters, Yongchang Qiu, Jason Jussif(Inflammation Research Foundation), Laura Carter(Inflammation Research Foundation), Clive R. Wood(Inflammation Research Foundation), Divya Chaudhary(Inflammation Research Foundation)
FEBS Letters
August 13, 2004
Cited by 772

Abstract

Engagement of the immunoinhibitory receptor, programmed death-1 (PD-1) attenuates T-cell receptor (TCR)-mediated activation of IL-2 production and T-cell proliferation. Here, we demonstrate that PD-1 modulation of T-cell function involves inhibition of TCR-mediated phosphorylation of ZAP70 and association with CD3zeta. In addition, PD-1 signaling attenuates PKCtheta activation loop phosphorylation in a cognate TCR signal. PKCtheta has been shown to be required for T-cell IL-2 production. A phosphorylated PD-1 peptide, corresponding to the C-terminal immunoreceptor tyrosine-switch motif (ITSM), acts as a docking site in vitro for both SHP-2 and SHP-1, while the phosphorylated peptide containing the N-terminal PD-1 immunoreceptor tyrosine based inhibitory motif (ITIM) associates only with SHP-2.


Related Papers

No related papers found

Powered by citation graph analysis